(MedPage Today) — Some say ACOs haven’t worked; others want to give them more time
Uncategorized
Valeant reports revenue increase, net income decrease in third quarter
Valeant Pharmaceuticals reported $2.8 billion in total revenues in the third quarter 2015, a 36% increase from the third quarter of last year, according to a press release.Net income for the third quarter was $51.7 million vs. $276.4 million in the thi…
Uncategorized
Linked social media–EMR databank may lead to better health outcomes
A linked electronic medical record and social media database could yield insights pertaining to a patient’s health, according to research published in BMJ Quality & Safety. Kevin Padrez, MD, a resident physician in the department of emergency medicine at the University of California, San Francisco, and colleagues conducted a study of 1,433 participants to assess such a database.
Uncategorized
Four advances in health technology we were supposed to have by Back to the Future Day
While some of the technology depicted in the 2015 of the film Back to the Future II actually has emerged, including voice activation, enormous flatscreen televisions, wearable technology and, incredibly, hoverboards, there are many other advancements s…
Uncategorized
Both micropulse photocoagulation, half-dose PDT may treat central serous chorioretinopathy
Both micropulse photocoagulation and half-dose verteporfin photodynamic therapy may reduce leakage, resolve subretinal fluid and increase visual acuity in the treatment of central serous chorioretinopathy, according to a study.The comparative, prospect…
Resumen: Oraya Therapeutics recibe las directrices de la sociedad profesional sobre la utilización de la radioterapia para la AMD húmeda en Alemania
NEWARK, California–(BUSINESS WIRE)–Oraya Therapeutics ha anunciado que la Sociedad alemana de oftalmología, la Sociedad de la Retina y la Asociación profesional de oftalmólogos alemanes, han emitido una opinión conjunta sobre el uso de la radioterapia junto con el sistema IRay® de radioterapia estereotáctica para la degeneración macular relacionada con la edad neovascular. El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de